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808 Abstracts September 2014was 39% at a median follow-up of 12.1 months. Early signiﬁcant postoper-
ative complications occurred in 52% of patients. The graft-related mortality
rate was 7%. The graft-related complication rate was 19%. During follow-up,
there were two recurrences of aortic infection and two recurrences of allo-
graft limb occlusion. Multivariate survival analysis identiﬁed age, chronic
renal disease, prosthetic infection, emergent procedure, and coronary dis-
ease as independent predictors for postoperative mortality.
Conclusion: This experience with cryopreserved aortic allografts in
aortic reconstructions shows an unsatisfactory 30-day survival rate, as well
as a substantial early graft-related complication rate. Longer follow-up is
needed in order to support the preferential use of cryopreserved allografts
based on their long-term behavior.
Prognostic Impact of Arterial Stiffness in Patients with Symptomatic
Peripheral Arterial Disease
Kals J., Lieberg J., Kampus P., Zagura M., Eha J., Zilmer M. Eur J Vasc
Endovasc Surg 2014;48:310-7.
Objectives: Arterial stiffness (AS) is increasingly recognized as an in-
dependent risk factor in different high-risk populations. Whether changes
in AS can predict prognosis in patients with symptomatic peripheral arterial
disease (PAD) has never been investigated. The aim of the present study was
to test the hypothesis that AS is an independent predictor of all-cause and
cardiovascular disease (CVD) mortality in patients with symptomatic PAD.
Methods: A cohort of 117 symptomatic PAD patients (aged 62.3 6
7.7 years) were prospectively recruited from the Department of Vascular
Surgery, Tartu University Hospital, between 2002 and 2010. The AS was
measured using pulse wave analysis and assessment of pulse wave velocity
(PWV).
Results: During the follow-up period (mean 4.1 6 2.2 years) there
were 32 fatal events. KaplaneMeier analysis showed that the probability
of all-cause and CVD mortality decreased with increasing small artery elas-
ticity (SAE), as estimated by the log-rank test (p = .004; p = .005, respec-
tively). By contrast, large artery elasticity, augmentation index, and aortic
and brachial PWV were not signiﬁcantly related to mortality. In a Cox pro-
portional hazard model, SAE above the median was associated with
decreased all-cause and CVD mortality after adjustment for confounding
factors: relative risk (RR), 0.37; 95% conﬁdence interval (CI), 0.17e0.81;
p = .01; RR, 0.11; 95% CI, 0.01e0.86; p = .04, respectively).
Conclusions: This study provides the ﬁrst evidence, obtained from an
observational study, that decreased small artery elasticity is an independent
predictor of all-cause and CVD mortality in patients with symptomatic
PAD.
Efﬁcacy of Revascularization for Critical Limb Ischemia in Patients
with End-stage Renal Disease
Yamamoto S., Hosaka A., Okamoto H., Shigematsu K., Miyata T.,
Watanabe T. Eur J Vasc Endovasc Surg 2014;48:318-26.
Objective: To evaluate the outcomes of surgical revascularization for
critical limb ischemia in patients with end-stage renal disease (ESRD).Patients and methods: From 2004 to 2010, 184 patients with 213
critically ischaemic limbs caused by arteriosclerosis were admitted to The
University of Tokyo Hospital. The outcomes of primarily surgical revascu-
larization-based treatments were retrospectively compared in patients with
ESRD (ESRD group: 79 patients, 101 limbs) and without ESRD (non-
ESRD group: 105 patients, 112 limbs) during the same period.
Results: Arterial reconstruction was performed on 56 limbs in 46 pa-
tients in the ESRD group and 78 limbs in 73 patients in the non-ESRD
group (55% vs. 70%; p = .03). Major amputation was performed in 6 of
48 limbs with patent grafts in the ESRD group because of uncontrolled
infection or progression of necrosis. The limb salvage rate after arterial
reconstruction was signiﬁcantly lower in the ESRD group than in the
non-ESRD group (p = .0019). The postoperative survival rate was lower
in the ESRD group than in the non-ESRD group, although this difference
was not signiﬁcant (p = .052). Associated cardiovascular disease and systemic
infection were the most frequent causes of death in the ESRD group. There
was no signiﬁcant difference in graft patency between the two groups after
distal bypass surgery; however, the limb salvage rate was signiﬁcantly lower
in the ESRD group than in the non-ESRD group (p = .03).
Conclusions: Critical limb ischemia associated with ESRD has a poor
prognosis. Infection control is particularly important for achievement of
good treatment outcomes.
The Effect of Deep Venous Stenting on Healing of Lower Limb
Venous Ulcers
George R., Verma H., Ram B., Tripathi R. Eur J Vasc Endovasc Surg
2014;48:332-8.
Objective: To report the outcomes of endovascular interventions on
deep veins in patients with venous ulcers (C6).
Methods: This was a retrospective review of a case series. All patients
with active venous ulceration who underwent endovascular interventions to
the deep venous system from February 2011 to June 2013 were included.
Patients with C6 disease who failed a trial of adequate compression therapy
or superﬁcial vein interventions were considered for evaluation of the deep
veins. Patients with deep vein reﬂux or without signiﬁcant venous reﬂux or
with a previous history of deep vein thrombosis underwent computed tomo-
graphic venogram or ascending venogram. In the absence of intravenous ul-
trasound trial ballooning to look for a “waist” to identify subtle lesions was
used. Lesions were stented with long Nitinol stents.
Results: Thirty-eight patients underwent deep vein stenting of 44
limbs with venous ulcers. The lesions were considered to be post-throm-
botic in 31 limbs and non-thrombotic iliac vein lesions in 13 limbs. A
mean of 1.8 stents were used per patient. There were no signiﬁcant compli-
cations associated with the interventions. At a median follow-up of 15
months, the primary and assisted primary patency rates were 94% and
97%, respectively. Sustained ulcer healing was achieved in 60% of limbs. A
further 20% of ulcers had reduced in size. Recurrent ulcers developed in
13% of limbs, and half of these healed with interventions for newly devel-
oped incompetence in superﬁcial veins.
Conclusion: Endovascular interventions to the deep veins appear to
be an effective adjunct in achieving the healing of recalcitrant ulcers.
